Trial Profile
Pharmacokinetics of intravenous telavancin in healthy subjects with varying degrees of renal impairment. A phase I, open-label, single-dose, three-centre study.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 Nov 2015
Price :
$35
*
At a glance
- Drugs Telavancin (Primary)
- Indications Bacterial infections
- Focus Pharmacokinetics
- 02 Nov 2015 New trial record